Herpes simplex virus type 1 (HSV-1) mutants impaired in the activities of the structural protein VP16 and the immediate-early (IE) proteins ICP0 and ICP4 establish a quiescent infection in human fibroblasts, with most cells retaining an inactive, repressed viral genome for sustained periods in culture. To date, the quiescent state has been considered stable, since it has been reversed only by provision of herpesviral proteins, such as ICP0, not by alteration of the cell physiological state. We report that the interaction of HSV-1 with human fibroblasts can be altered significantly by transient treatment of cultures with sodium arsenite, an inducer of heat shock and oxidative stress, or gramicidin D, a toxin that selectively permeabilizes cell membranes, prior to infection. These regimens stimulated gene expression from IE-deficient HSV-1 mutants in a promoter sequence-independent manner and also overcame the replication defect of ICP0-null mutants. Reactivation of gene expression from quiescent HSV-1 genomes and the resumption of virus replication were observed following addition of arsenite or gramicidin D to cultures. Both agents induced reorganization of nuclear domain 10 structures, the sites of quiescent genomes, but appeared to do so through different mechanisms. The results demonstrate that the physiological state of the cell is important in determining the outcome of infection with IE-deficient HSV-1 and show novel methods for reactivating quiescent HSV-1 in fibroblasts with a high efficiency.Transcription of the herpes simplex virus type 1 (HSV-1) genome at early stages of infection is controlled by the activities of three viral proteins, VP16, ICP4, and ICP0. VP16 is a virion component that stimulates immediate-early (IE) transcription through interaction with the cellular proteins Oct-1 and HCF-1 (51, 77). ICP4 is an IE protein that is essential for early and late gene expression, acting on basal cellular transcription factors (10,64,80). The IE protein ICP0 exerts a general stimulatory effect on HSV-1 transcription and is important for initiation of the viral gene expression program (17,19,31,61,68).The VP16 and ICP4 proteins can be viewed as conventional transcription activators since they interact with cellular factors that localize to promoter regions of the viral genome. In contrast, the effects of ICP0 are not promoter specific or even restricted to the HSV-1 genome, since the protein stimulates gene expression from a variety of plasmids and viruses (3,18,30,31,48,52). One of the most striking features of ICP0 is its effect on cellular intranuclear structures known as promyelocytic leukemia (PML) bodies or nuclear domain 10 (ND10). Early in infection, ICP0 localizes to ND10 and directs the disruption of these bodies (21,22). Protein components of ND10, including the PML protein itself, are targeted for degradation due to a ubiquitin E3 ligase activity that requires the RING domain of ICP0 (6,21,25). HSV-1 mutants that lack the ICP0 coding region exhibit a multiplicity-and cell type-dependent def...